GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Biodiversity Research  (3)
  • 1
    In: Cytometry Part A, Wiley, Vol. 73A, No. 11 ( 2008-11), p. 1093-1099
    Abstract: Adoptive transfer of antigen‐specific T‐cells has shown therapeutic successes in the treatment of tumors in patients with metastatic melanoma. Tumor antigen‐specific T‐lymphocytes, however, occur only at low frequencies in a small proportion of patients. This low T‐lymphocyte frequency together with the difficulties associated with in vitro generation of T‐lymphocytes specific for cancers other than melanoma hampers adoptive T cell therapy. To make adoptive T‐cell therapy more uniformly applicable, strategies were developed at transferring tumor‐specificity to primary human T‐lymphocytes via antibody (Ig) or T‐cell receptor (TCR) molecules. We exploited the selection power of phage display that allows for the testing of tens of billions of individual clones with a high‐throughput selection of Fabs with peptide/MHC complex binding capacity. Following in vitro selection, human “TCR‐like” Fab fragments have been functionally expressed on human T‐lymphocytes, resulting in MHC‐restricted, tumor‐specific lysis and cytokine production. Currently, we have extended our selections to a panel of class I and II MHC‐restricted MAGE and other tumor‐specific epitopes, and would like to propose that phage display represents a technology able to expand T‐cell therapy to numerous tumor types. © 2008 International Society for Advancement of Cytometry
    Type of Medium: Online Resource
    ISSN: 1552-4922 , 1552-4930
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2008
    detail.hit.zdb_id: 2180639-1
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: The Journal of Gene Medicine, Wiley, Vol. 9, No. 7 ( 2007-07), p. 561-570
    Abstract: T cell receptor (TCR) gene therapy represents an attractive anti‐cancer treatment but requires further optimization of its efficacy and safety in clinically relevant models, such as those using a tumor antigen and TCR of human origin. Currently, however, there is no consensus as to what protocol is most optimal for retroviral human TCR gene transfer into primary murine T cells, most notably with respect to virus pseudo‐type. Methods Primary murine T cells were transduced, expanded and subsequently tested for transgene expression, proliferation and antigen‐specific function. To this end, murine leukemia virus (MLV) retroviruses were produced upon transfection of various packaging cells with genes encoding either green fluorescent protein (GFP) or TCRαβ specific for human melanoma antigen gp100 280–288 and the helper elements GAG/POL and ENV. Next to viral pseudotyping, the following parameters were studied: T cell densities; T cell activation; the amounts of IL‐2 and the source of serum used to supplement medium. Results The pseudo‐type of virus produced by packaging cells critically determines T cell transduction efficiencies. In fact, MLV‐A and MLV‐E pseudo‐typed viruses derived from a co‐culture of Phoenix‐A and 293T cells resulted in T cell transduction efficiencies that were two‐fold higher than those based on retroviruses expressing either VSV‐G, GALV, MLV‐A or MLV‐E envelopes. In addition, T cell densities during transduction were inversely related to transduction efficiencies. Further optimization resulted in transduction efficiencies of over 90% for GFP, and 68% for both a murine and a human (i.e. murinized) TCR. Importantly, TCR‐transduced T cells proliferate (i.e. showing a log increase in cell number in a few days) and show antigen‐specific function. Conclusions We set up a quick and versatile method to genetically modify primary murine T cells based on transient production of TCR‐positive retroviruses, and show that retroviral gene transfer of a human TCR into primary murine T cells is critically improved by viral pseudo‐typing with both MLV‐A and MLV‐E envelopes. Copyright © 2007 John Wiley & Sons, Ltd.
    Type of Medium: Online Resource
    ISSN: 1099-498X , 1521-2254
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2007
    detail.hit.zdb_id: 2002203-7
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Cytometry, Wiley, Vol. 48, No. 3 ( 2002-07), p. 124-135
    Abstract: Flow cytometric fluorescence resonance energy transfer (FCET) is an efficient method to map associations between biomolecules because of its high sensitivity to changes in molecular distances in the range of 1–10 nm. However, the requirement for a dual‐laser instrument and the need for a relatively high signal‐to‐noise system (i.e., high expression level of the molecules) pose limitations to a wide application of the method. Methods Antibodies conjugated to cyanines 3 and 5 (Cy3 and Cy5) were used to label membrane proteins on the cell surface. FCET measurements were made on a widely used benchtop dual‐laser flow cytometer, the FACSCalibur, by using cell‐by‐cell analysis of energy transfer efficiency. Results To increase the accuracy of FCET measurements, we applied a long wavelength donor–acceptor pair, Cy3 and Cy5, which beneficially affected the signal‐to‐noise ratio in comparison with the classic pair of fluorescein and rhodamine. A new algorithm for cell‐by‐cell correction of autofluorescence further improved the sensitivity of the technique; cell subpopulations with only slightly different FCET efficiencies could be identified. The new FCET technique was tested on various direct and indirect immunofluorescent labeling strategies. The highest FCET values could be measured when applying direct labeling on both (donor and acceptor) sides. Upon increasing the complexity of the labeling scheme by introducing secondary antibodies, we detected a decrease in the energy transfer efficiency. Conclusions We developed a new FCET protocol by applying long wavelength excitation and detection of fluorescence and by refining autofluorescence correction. The increased accuracy of the new method makes cells with low receptor expression amenable to FCET investigation, and the new approach can be implemented easily on a commercially available dual‐laser flow cytometer, such as a FACSCalibur. Cytometry 48:124–135, 2002. © 2002 Wiley‐Liss, Inc.
    Type of Medium: Online Resource
    ISSN: 0196-4763 , 1097-0320
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2002
    detail.hit.zdb_id: 2180639-1
    detail.hit.zdb_id: 1474272-X
    detail.hit.zdb_id: 2180651-2
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...